We are live on ! Find out more
CFM

Capricorn Fund Managers Portfolio holdings

AUM $1.27B
1-Year Est. Return 70.17%
This Fund
S&P 500
This Quarter Est. Return
+29.44%
1 Year Est. Return
+70.17%
3 Year Est. Return
+169.21%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$415M
AUM Growth
+$117M
Cap. Flow
+$84.1M
Cap. Flow %
20.26%
Top 10 Hldgs %
35.96%
Holding
106
New
47
Increased
17
Reduced
15
Closed
24

Top Buys

Rank Stock Value
1
ZYME icon
Zymeworks
ZYME
+$22.3M
2
GPCR icon
Structure Therapeutics
GPCR
+$10.3M
3
BLFS icon
BioLife Solutions
BLFS
+$9.91M
4
NUVB icon
Nuvation Bio
NUVB
+$9.84M
5
ALAB icon
Astera Labs
ALAB
+$8.36M

Top Sells

Rank Stock Value
1
TARS icon
Tarsus Pharmaceuticals
TARS
+$16.3M
2
VERA icon
Vera Therapeutics
VERA
+$13.1M
3
PHR icon
Phreesia
PHR
+$11.4M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$10.7M
5
REAL icon
The RealReal
REAL
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 44.36%
2 Technology 15.14%
3 Industrials 8.91%
4 Communication Services 8.61%
5 Consumer Discretionary 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REAL icon
26
The RealReal
REAL
$1.53B
$6.2M 1.49%
392,897
-796,593
-67% -$10.4M
TERN
27
DELISTED
Terns Pharmaceuticals
TERN
$6.12M 1.47%
+151,436
New +$3.5M
BRK.B icon
28
Berkshire Hathaway Class B
BRK.B
$1.12T
$5.96M 1.44%
11,854
-1,086
-8% -$540K
META icon
29
Meta Platforms (Facebook)
META
$1.5T
$5.95M 1.43%
9,019
-4,038
-31% -$2.7M
DAY
30
DELISTED
Dayforce
DAY
$5.88M 1.42%
+85,033
New +$5.85M
TXNM
31
TXNM Energy Inc
TXNM
$5.94B
$5.21M 1.26%
+88,529
New +$5.11M
RNAM
32
DELISTED
Avidity Biosciences
RNAM
$4.94M 1.19%
68,463
+57,663
+534% +$3.72M
KVUE icon
33
Kenvue
KVUE
$36.5B
$4.87M 1.17%
+282,485
New +$4.62M
LOAR icon
34
Loar Holdings
LOAR
$7.07B
$4.76M 1.15%
+70,000
New +$5.1M
WBD icon
35
Warner Bros
WBD
$65.4B
$4.72M 1.14%
+163,668
New +$3.83M
QSR icon
36
Restaurant Brands International
QSR
$25.3B
$4.44M 1.07%
65,089
-5,779
-8% -$398K
APO icon
37
Apollo Global Management
APO
$74.6B
$4.3M 1.04%
29,693
+16,386
+123% +$2.18M
PFE icon
38
Pfizer
PFE
$145B
$4.12M 0.99%
+165,569
New +$4.18M
APP icon
39
Applovin
APP
$141B
$4.04M 0.97%
+6,000
New +$3.78M
CFLT
40
DELISTED
Confluent
CFLT
$3.94M 0.95%
+130,391
New +$3.2M
UNP icon
41
Union Pacific
UNP
$173B
$3.91M 0.94%
16,890
-1,289
-7% -$294K
HI
42
DELISTED
Hillenbrand
HI
$3.9M 0.94%
+122,961
New +$3.79M
MDGL icon
43
Madrigal Pharmaceuticals
MDGL
$11.1B
$3.84M 0.93%
+6,600
New +$3.37M
PEP icon
44
PepsiCo
PEP
$190B
$3.76M 0.91%
26,166
-10,512
-29% -$1.54M
BTSG icon
45
BrightSpring Health Services
BTSG
$12.4B
$3.75M 0.9%
+100,000
New +$3.35M
KGS icon
46
Kodiak Gas Services
KGS
$5.86B
$3.74M 0.9%
+100,000
New +$3.54M
LIN icon
47
Linde
LIN
$221B
$3.46M 0.83%
8,114
-716
-8% -$307K
OXY icon
48
Occidental Petroleum
OXY
$54.8B
$3.16M 0.76%
76,877
-7,676
-9% -$320K
CWAN
49
DELISTED
Clearwater Analytics
CWAN
$3.01M 0.72%
+124,611
New +$2.5M
FOLD
50
DELISTED
Amicus Therapeutics
FOLD
$3M 0.72%
+210,674
New +$2.07M
1
2
3 4 5

Similar funds

TC
Teilinger Capital Houston, Texas $1.27B AUM 5.87% 1-Year Est. Return
EIA
Edgemoor Investment Advisors Bethesda, Maryland $1.27B AUM 25.83% 1-Year Est. Return
CAM
Cozad Asset Management Champaign, Illinois $1.27B AUM 31.6% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
NCM
Novare Capital Management Charlotte, North Carolina $1.26B AUM 20.28% 1-Year Est. Return
TWP
Triad Wealth Partners Lawrence, Kansas $1.26B AUM 17.86% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

Capricorn Fund Managers's Q4 2025 Portfolio in Review

As of Q4 2025, Capricorn Fund Managers held 106 positions worth $415M, up 39% from $298M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Capricorn Fund Managers deployed $84.1M of net new capital in Q4 2025, opening 47 new positions and adding to 17 existing holdings. Its largest new stake was Zymeworks: 1,022,840 shares worth $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Tarsus Pharmaceuticals, an estimated $16.3M trimmed.

  • Capricorn Fund Managers's largest Q4 2025 buy was Zymeworks: 1,022,840 shares worth $26.9M.
  • Capricorn Fund Managers added most to Waystar Holding Corp in Q4 2025, an estimated $8.31M increase.
  • Capricorn Fund Managers's biggest Q4 2025 reduction was Tarsus Pharmaceuticals, cutting an estimated $16.3M.
  • Capricorn Fund Managers fully exited Vera Therapeutics in Q4 2025, selling an estimated $13.1M.
  • Capricorn Fund Managers's ten largest holdings make up 36% of its $415M portfolio in Q4 2025.
  • Capricorn Fund Managers opened 47 new positions and closed 24 in Q4 2025.
  • Capricorn Fund Managers's portfolio value rose 39% quarter-over-quarter to $415M.

Based on Capricorn Fund Managers's 13F filing for Q4 2025, filed 21 Jan 2026.